News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Nancy L. Reaven, MA

Articles by Nancy L. Reaven, MA

All-Cause Costs Increase Exponentially with Increased Chronic Kidney Disease Stage

ByLadan Golestaneh, MD, MS,Paula J. Alvarez, RPh, MPH, MBA,Nancy L. Reaven, MA,Susan E. Funk, MBA, FACHE,Karen J. McGaughey, PhD,Alain Romero, PhD,Melanie S. Brenner, PharmD, BCPS,Macaulay Onuigbo, MD, MSc, MBA

June 21st 2017

Evaluation of Clinical Outcomes and Costs Based on Prescribed Dose Level of Renin-Angiotensin-Aldosterone System Inhibitors

ByMurray Epstein, MD,Paula J. Alvarez, RPh, MPH, MBA,Nancy L. Reaven, MA,Susan E. Funk, MBA, FACHE,Karen J. McGaughey, PhD,Melanie S. Brenner, PharmD, BCPS,Wade Benton, PharmD,Ladan Golestane

August 31st 2016

Evaluation of the Treatment Gap Between Clinical Guidelines and the Utilization of Renin-Angiotensin-Aldosterone System Inhibitors

ByMurray Epstein, MD,Nancy L. Reaven, MA,Susan E. Funk, MBA,Karen J. McGaughey, PhD,Nina Oestreicher, PhD,John Knispel, MD

September 16th 2015

Latest Updated Articles

Trending on AJMC

MASH Fibrosis, Not Resolution, Predicts Mortality: Zobair Younossi, MD

A New Mechanism for DME in the BRUNELLO Trial: Donald J. D’Amico, MD

Full POLARGO Data Reveal OS, Safety for Pola-R-GemOx in DLBCL

FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia

Big Data, MIGS Are Crucial Areas of Glaucoma Treatment: AAO Panel